BARDA
Cepheid Gets $28M From BARDA for SARS-CoV-2 Tests
The funding is for the firm's SARS-CoV-2, pan-coronavirus, and multiplex SARS-CoV-2, influenza, and respiratory syncytial virus tests, according to BARDA.
HHS, DoD Award $35.1M to LightDeck Diagnostics to Boost Production of COVID-19 POC Tests
LightDeck said its COVID-19 Ultra-Rapid Antigen and Total Antibody tests will provide lab-quality results within five minutes wherever testing is needed.
Selux Diagnostics Nabs Additional $14.6M in BARDA Funding
After completing its first clinical trial, Selux will use the funding to commercialize its Next Generation Phenotyping platform for rapid antimicrobial testing.
BARDA Venture Capital Program Dedicates Up To $500M for Pandemic Preparedness
The BARDA Ventures program will partner with the nonprofit Global Health Investment Corporation to launch a global health security fund.
T2 Biosystems Q1 Revenues Nearly Triple
Product revenues were up 345 percent, as the firm increased US sepsis test utilization by 85 percent and sold four T2Dx instruments.